» Articles » PMID: 19049658

Pharmacokinetic Predictions in Children by Using the Physiologically Based Pharmacokinetic Modelling

Overview
Specialty Pharmacology
Date 2008 Dec 4
PMID 19049658
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Nowadays, 50-90% of drugs used in children have never been actually studied in this population. Consequently, either our children are often exposed to the risk of adverse drug events or to lack of efficacy, or they are unable to benefit from a number of therapeutic advances offered to adults, as no clinical study has been properly performed in children. Actually the main methods used to calculate the dose for a child are based on allometric methods taking into account different categories of age, the body weight and/or the body surface area. Unfortunately, these calculation methods consider the children as small adults, which is not the case. Physiologically based pharmacokinetics is one way to integrate the physiological changes occurring in the childhood and to anticipate their impact on the pharmacokinetic processes: absorption, distribution, metabolism and excretion/elimination. From different examples, the application of this modelling approach is discussed as a possible and valuable method to minimize the ethical and technical difficulties of conducting research in children.

Citing Articles

Integration of Ontogeny-Based Changes for Predicting the Exposure of Diphenhydramine in the Pediatric Population: A PBPK Modeling Approach.

Zamir A, Rasool M, Alqahtani F, Alqhtani H, Ahmad T Pharmaceutics. 2025; 16(12.

PMID: 39771532 PMC: 11677874. DOI: 10.3390/pharmaceutics16121553.


Prediction of pharmacokinetic values of two various dosages of caffeine in premature neonates with apnea.

Faramarzi F, Shiran M, Rafati M, Farhadi R, Salehifar E, Nakhshab M Indian J Pharmacol. 2021; 53(2):108-114.

PMID: 34100394 PMC: 8265417. DOI: 10.4103/ijp.IJP_504_19.


Antibiotic Resistance in Pediatric Infections: Global Emerging Threats, Predicting the Near Future.

Romandini A, Pani A, Schenardi P, Pattarino G, De Giacomo C, Scaglione F Antibiotics (Basel). 2021; 10(4).

PMID: 33917430 PMC: 8067449. DOI: 10.3390/antibiotics10040393.


Computational Approaches in Preclinical Studies on Drug Discovery and Development.

Wu F, Zhou Y, Li L, Shen X, Chen G, Wang X Front Chem. 2020; 8:726.

PMID: 33062633 PMC: 7517894. DOI: 10.3389/fchem.2020.00726.


Prediction of lisinopril pediatric dose from the reference adult dose by employing a physiologically based pharmacokinetic model.

Rashid M, Sarfraz M, Arafat M, Hussain A, Abbas N, Sadiq M BMC Pharmacol Toxicol. 2020; 21(1):56.

PMID: 32727574 PMC: 7389632. DOI: 10.1186/s40360-020-00429-y.